News Releases

Date	Title
6/30/2020	Genetron Health Presents Cancer Clinical Research Data at AACR Virtual Annual Meeting Highlighting the Sensitivity and Specificity of its NGS Technology in Precision Oncology
6/19/2020	Genetron Health Announces Pricing of Initial Public Offering
6/11/2020	Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public Hospitals
6/6/2020	Genetron Health Receives FDA Emergency Use Authorization for SARS-CoV-2 RNA Test and Approval for Export by Chinese Authority
5/20/2020	Genetron Health Announces Strategic Collaboration with DARUI on GENETRON S5 Platform
4/20/2020	Genetron Health Announces Forthcoming Unveiling of Its Cancer Research Papers at the AACR Annual Meeting
4/10/2020	Genetron Health Appoints Former FDA Senior Officer Dr. Yun-Fu Hu as Chief Medical Officer
4/7/2020	Genetron Health Announces Its Novel Coronavirus Nucleic Acid Detection Kit Is CE Marked and FDA-EUA Application Accepted, with Three Laboratories Passing NCCL’s COVID-19 EQA
3/20/2020	Genetron Health Contributes to China’s First Expert Consensus Statement on the Standardized Clinical Application of NGS Testing for Oncology
3/12/2020	Genetron Health Responds to Wuhan Huoshenshan Hospital's Request with Donation of NGS Platforms
2/21/2020	Genetron Health Announces Strategic Partnership with InnoCare on Biomarker-Driven Oncology Drug Development
2/13/2020	Genetron Health Announces NMPA Approval of its 8-gene Lung Cancer Assay and NGS Platform GENETRON S2000
1/30/2020	Genetron Health to Participate in China National Key Research and Development Project on Cancer Early Screening
1/14/2020	Genetron Health Announces Strategic Partnership with the National Brain Tumor Registry of China